ELISA in Relapsed/Refractory MM
Massachusetts General Hospital
Massachusetts General Hospital
Wake Forest University Health Sciences
Celgene
University of Miami
Pfizer
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Massachusetts General Hospital
Assistance Publique - Hôpitaux de Paris
Massachusetts General Hospital
Shandong New Time Pharmaceutical Co., LTD
Icahn School of Medicine at Mount Sinai
Institut Curie
Ontario Clinical Oncology Group (OCOG)
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
GlaxoSmithKline
Amgen
AbbVie
City of Hope Medical Center
Celgene
Rapa Therapeutics LLC
Hadassah Medical Organization
Gruppo Italiano Malattie EMatologiche dell'Adulto
Intergroupe Francophone du Myelome
SWOG Cancer Research Network
University of Leeds
Peter MacCallum Cancer Centre, Australia
The First Affiliated Hospital of Xiamen University
pharmaand GmbH
Hellenic Society of Hematology
University of Leeds
European Myeloma Network B.V.
University of Heidelberg Medical Center
Oncotherapeutics
Canadian Cancer Trials Group
Antengene Corporation
Hrain Biotechnology Co., Ltd.
Thomas Jefferson University
Hackensack Meridian Health
Tulane University
University of Arkansas
University of Arkansas
Merck Sharp & Dohme LLC
Fred Hutchinson Cancer Center
Boston VA Research Institute, Inc.
Novartis
Masonic Cancer Center, University of Minnesota
University Health Network, Toronto
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute